|
Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings
|
Purchase of Assets and Related Global Commercialization Rights for Oral 9-cis-Retinol (Zuretinol) for Rare Forms of Childhood Blindness. Clinical Stage Asset Has Potential for First Approved Oral Therapy for Lebe...
Full "IntellAsia: Resources" article
|
|